Obesity-associated glomerular inflammation increases albuminuria without renal histological changes

FEBS Open Bio

Volumn 8, Issue 4, 2018, Pages 664-670

  Mima, Akira ^a   Yasuzawa, Toshinori ^b   King, George L ^c   Ueshima, Shigeru ^b  

^a KINDAI UNIVERSITY NARA HOSPITAL   (Japan)

^b KINKI UNIVERSITY   (Japan)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

albuminuria; CKD; Inflammation; NF B; obesity

Indexed keywords

EID: 85042447878     PISSN: 22115463     EISSN: None     Source Type: Journal    
DOI: 10.1002/2211-5463.12400     Document Type: Article

References (26)

1. Madero M, Katz R, Murphy R, Newman A, Patel K, Ix J, Peralta C, Satterfield S, Fried L, Shlipak M et al. (2017) Comparison between different measures of body fat with kidney function decline and incident CKD. Clin J Am Soc Nephrol 12, 893–903.
2. Herrington WG, Smith M, Bankhead C, Matsushita K, Stevens S, Holt T, Hobbs FD, Coresh J and Woodward M (2017) Body-mass index and risk of advanced chronic kidney disease: prospective analyses from a primary care cohort of 1.4 million adults in England. PLoS One 12, e0173515.
3. Mima A, Ohshiro Y, Kitada M, Matsumoto M, Geraldes P, Li C, Li Q, White GS, Cahill C, Rask-Madsen C et al. (2011) cC-beta-induced insulin receptor substrate-1 dysfunction and insulin resistance in rat models of diabetes and obesity. Kidney Int 79, 883–896.
4. Ryden L and Mellbin L (2017) New hope for people with dysglycemia and cardiovascular disease manifestations: reduction of acute coronary events with pioglitazone. Circulation 135, 1894–1896.
5. Siddiqi FS and Advani A (2013) Endothelial-podocyte crosstalk: the missing link between endothelial dysfunction and albuminuria in diabetes. Diabetes 62, 3647–3655.
6. Carrero JJ, Grams ME, Sang Y, Ärnlöv J, Gasparini A, Matsushita K, Qureshi AR, Evans M, Barany P, Lindholm B et al. (2017) Albuminuria changes are associated with subsequent risk of end-stage renal disease and mortality. Kidney Int 91, 244–251.
7. Brantsma AH, Bakker SJ, Hillege HL, de Zeeuw D, de Jong PE, Gansevoort RT; PREVEND Study Group (2005) Urinary albumin excretion and its relation with C-reactive protein and the metabolic syndrome in the prediction of type 2 diabetes. Diabetes Care 28, 2525–2530.
8. Lin J, Hu FB, Rimm EB, Rifai N and Curhan GC (2006) The association of serum lipids and inflammatory biomarkers with renal function in men with type II diabetes mellitus. Kidney Int 69, 336–342.
9. Stehouwer CD, Fischer HR, van Kuijk AW, Polak BC and Donker AJ (1995) Endothelial dysfunction precedes development of microalbuminuria in IDDM. Diabetes 44, 561–564.
10. Schalkwijk CG, Poland DC, van Dijk W, Kok A, Emeis JJ, Dräger AM, Doni A, van Hinsbergh VW and Stehouwer CD (1999) Plasma concentration of C-reactive protein is increased in type I diabetic patients without clinical macroangiopathy and correlates with markers of endothelial dysfunction: evidence for chronic inflammation. Diabetologia 42, 351–357.
11. Mima A, Qi W, Hiraoka-Yamomoto J, Park K, Matsumoto M, Kitada M, Li Q, Mizutani K, Yu E, Shimada T et al. (2012) Retinal not systemic oxidative and inflammatory stress correlated with VEGF expression in rodent models of insulin resistance and diabetes. Invest Ophthalmol Vis Sci 53, 8424–8432.
12. Siebenlist U, Franzoso G and Brown K (1994) Structure, regulation and function of NF-kappa B. Annu Rev Cell Biol 10, 405–455.
13. Wang H, Chen X, Su Y, Paueksakon P, Hu W, Zhang MZ, Harris RC, Blackwell TS, Zent R and Pozzi A (2015) p47(phox) contributes to albuminuria and kidney fibrosis in mice. Kidney Int 87, 948–962.
14. Giacco F, Du X, D'Agati VD, Milne R, Sui G, Geoffrion M and Brownlee M (2014) Knockdown of glyoxalase 1 mimics diabetic nephropathy in nondiabetic mice. Diabetes 63, 291–299.
15. Billings FTT, Pretorius M, Schildcrout JS, Mercaldo ND, Byrne JG, Ikizler TA and Brown NJ (2012) Obesity and oxidative stress predict AKI after cardiac surgery. J Am Soc Nephrol 23, 1221–1228.
16. Suzuki D, Miyazaki M, Naka R, Koji T, Yagame M, Jinde K, Endoh M, Nomoto Y and Sakai H (1995) In situ hybridization of interleukin 6 in diabetic nephropathy. Diabetes 44, 1233–1238.
17. Gohda T, Niewczas MA, Ficociello LH, Walker WH, Skupien J, Rosetti F, Cullere X, Johnson AC, Crabtree G, Smiles AM et al. (2012) Circulating TNF receptors 1 and 2 predict stage 3 CKD in type 1 diabetes. J Am Soc Nephrol 23, 516–524.
18. Gohda T, Maruyama S, Kamei N, Yamaguchi S, Shibata T, Murakoshi M, Horikoshi S, Tomino Y, Ohsawa I, Gotoh H et al. (2017) Circulating TNF receptors 1 and 2 predict mortality in patients with end-stage renal disease undergoing dialysis. Sci Rep 7, 43520.
19. Petecchia L, Sabatini F, Usai C, Caci E, Varesio L and Rossi GA (2012) Cytokines induce tight junction disassembly in airway cells via an EGFR-dependent MAPK/ERK1/2-pathway. Lab Invest 92, 1140–1148.
20. Nakamura T, Kawagoe Y, Matsuda T, Ueda A, Ueda Y, Takahashi Y, Tanaka A and Koide H (2004) Effect of granulocyte and monocyte adsorption apheresis on urinary albumin excretion and plasma endothelin-1 concentration in patients with active ulcerative colitis. Blood Purif 22, 499–504.
21. Deji N, Kume S, Araki S, Soumura M, Sugimoto T, Isshiki K, Chin-Kanasaki M, Sakaguchi M, Koya D, Haneda M et al. (2009) Structural and functional changes in the kidneys of high-fat diet-induced obese mice. Am J Physiol Renal Physiol 296, F118–F126.
22. Vaidya VS, Niewczas MA, Ficociello LH, Johnson AC, Collings FB, Warram JH, Krolewski AS and Bonventre JV (2011) Regression of microalbuminuria in type 1 diabetes is associated with lower levels of urinary tubular injury biomarkers, kidney injury molecule-1, and N-acetyl-beta-D-glucosaminidase. Kidney Int 79, 464–470.
23. Reddy MA, Sumanth P, Lanting L, Yuan H, Wang M, Mar D, Alpers CE, Bomsztyk K and Natarajan R (2014) Losartan reverses permissive epigenetic changes in renal glomeruli of diabetic db/db mice. Kidney Int 85, 362–373.
24. Kanamori H, Matsubara T, Mima A, Sumi E, Nagai K, Takahashi T, Abe H, Iehara N, Fukatsu A, Okamoto H et al. (2007) Inhibition of MCP-1/CCR2 pathway ameliorates the development of diabetic nephropathy. Biochem Biophys Res Commun 360, 772–777.
25. de Zeeuw D, Bekker P, Henkel E, Hasslacher C, Gouni-Berthold I, Mehling H, Potarca A, Tesar V, Heerspink HJ, Schall TJ; CCX140-B Diabetic Nephropathy Study Group (2015) The effect of CCR2 inhibitor CCX140-B on residual albuminuria in patients with type 2 diabetes and nephropathy: a randomised trial. Lancet Diabetes Endocrinol 3, 687–696.
26. Mima A, Kitada M, Geraldes P, Li Q, Matsumoto M, Mizutani K, Qi W, Li C, Leitges M, Rask-Madsen C et al. (2012) Glomerular VEGF resistance induced by PKCdelta/SHP-1 activation and contribution to diabetic nephropathy. FASEB J 26, 2963–2974.